학술논문

Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD.
Document Type
journal article
Source
BMC Pulmonary Medicine; 7/20/2016, Vol. 16, p1-13, 13p, 4 Color Photographs, 1 Diagram, 4 Charts, 2 Graphs
Subject
PHARMACOKINETICS
BRONCHODILATOR agents
OBSTRUCTIVE lung diseases
GLYCOPYRROLATE
ADRENOCORTICAL hormones
HYDROCARBONS
ADRENERGIC beta agonists
CLINICAL trials
COMPARATIVE studies
CROSSOVER trials
DOSE-effect relationship in pharmacology
RESEARCH methodology
MEDICAL cooperation
QUINOLONE antibacterial agents
RESEARCH
STATISTICAL sampling
SPIROMETRY
EVALUATION research
RANDOMIZED controlled trials
TREATMENT effectiveness
VITAL capacity (Respiration)
BLIND experiment
INHALATION administration
THERAPEUTICS
Language
ISSN
14712466
Abstract
Copyright of BMC Pulmonary Medicine is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)